Surgical treatment of gastric, enteric pancreatic endocrine tumors. Part 2. treatment of hepatic metastases (Q33991956)

30 July 2017

1 reference

title

Surgical treatment of gastric, enteric pancreatic endocrine tumors. Part 2. treatment of hepatic metastases (English)

1 reference

30 July 2017

Kianmanesh R

1

1 reference

30 July 2017

O'Toole D

2

1 reference

30 July 2017

Sauvanet A

3

1 reference

30 July 2017

Ruszniewski P

4

1 reference

30 July 2017

Belghiti J

5

1 reference

30 July 2017

1 July 2005

1 reference

30 July 2017

1 reference

30 July 2017

142

1 reference

30 July 2017

4

1 reference

30 July 2017

208-219

1 reference

Management of neuroendocrine liver metastases

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Result of liver resection as treatment for metastases from noncolorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Karnofsky memorial lecture. An odyssey in the land of small tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic resection for metastatic neuroendocrine carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Neuroendocrine metastases of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic neuroendocrine metastases: does intervention alter outcomes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

The surgical management of pancreatic neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: A 15-year single center prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Natural history of neuroendocrine enteropancreatic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic surgery for metastases from neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

The management of patients with advanced carcinoid tumors and islet cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Transcatheter chemoembolization of progressive carcinoid liver metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Laparoscopic radiofrequency ablation of neuroendocrine liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Laparoscopic radiofrequency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Radiofrequency Ablation of 100 Hepatic Metastases with a Mean Follow-Up of More Than 1 Year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic Tumors Treated with Percutaneous Radio-frequency Ablation: CT and MR Imaging Follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Resection of liver metastases from colorectal cancer: the real impact of the surgical margin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Surgical treatment of colorectal cancer metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatectomy for liver metastases from breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Treatment of hepatic metastases from gastroenteropancreatic neuroendocrine tumors: role of liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Indications and results of liver transplantation in patients with neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for treatment of metastatic neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for neuroendocrine tumors: progress and uncertainty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Operative management of islet-cell tumors arising in the head of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Imaging appearances of metastases from neuroendocrine tumours of the pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Carcinoid tumors of the abdomen: CT features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Carcinoid metastases to the liver: role of triple-phase helical CT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Revealing hepatic metastases from colorectal cancer: value of combined helical CT during arterial portography and CT hepatic arteriography with a unified CT and angiography system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

The small remnant liver after major liver resection: how common and how relevant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Portal vein embolization: rationale, technique and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

[Portal vein embolization prior to hepatectomy. Techniques, indications and results]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Body surface area and body weight predict total liver volume in Western adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Aggressive surgery for metastatic liver neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Prognosis and survival in patients with gastrointestinal tract carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for malignant disease. Results in 93 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for metastatic carcinoid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Role of liver transplantation in the treatment of unresectable liver cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Results of liver transplantation for gastroenteropancreatic tumor metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for metastatic neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Multimodality treatment for gastric carcinoid tumor with liver metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Therapeutic alternatives in metastatic neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Treatment of liver metastases in patients with neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

ISLET CELL TUMORS OF THE PANCREAS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Surgery for midgut carcinoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Role of liver transplantation in the management of metastatic neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Liver transplantation for metastatic neuroendocrine tumor disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Proliferation of antigen MIB-1 in metastatic carcinoid tumours removed at liver transplantation: relevance to prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Hepatic resection and transplantation for primary carcinoid tumors of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

Living donor liver transplantation: present and future.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-7697%2805%2980906-8

10.1016/S0021-7697(05)80906-8

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference